ArticleCancer science2025

Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study.

Chigusa Morizane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.